Dextran 40-containing infusion fluids and corneal swelling: a specular microscopic study

Area of Science:

• Ophthalmology
• Corneal Physiology
• Pharmacology

Background:

• Corneal swelling is a significant issue in ophthalmology.
• Understanding factors that modulate corneal hydration is crucial for eye health.
• Ouabain is known to induce corneal swelling by inhibiting Na+/K+-ATPase.

Purpose of the Study:

• To investigate the effect of dextran 40 on ouabain-induced corneal swelling.
• To determine if dextran 40 provides a protective effect against corneal edema.
• To assess the duration of dextran 40's influence on corneal hydration.

Main Methods:

• Corneal swelling was induced using 10(-5)M ouabain in infusion fluids.
• Specular microscopy was employed to measure corneal thickness.
• Dextran 40 was added to the infusion solution to observe its effect on swelling.
• Corneas were exposed to ouabain for varying time intervals.

Main Results:

• Dextran 40 demonstrated an inhibitory effect on corneal swelling in functionally impaired corneas.
• Upon removal of dextran 40, corneas rapidly swelled to levels comparable to those without dextran 40.
• Short-term ouabain stress followed by dextran 40 exposure resulted in a lasting protective effect, even after dextran 40 removal.

Conclusions:

• Dextran 40 can transiently inhibit corneal swelling.
• The protective effect of dextran 40 against corneal edema is time-dependent.
• Further research may explore dextran 40's potential therapeutic applications in managing corneal swelling.